Liquidia Corp. (LQDA)
70.28
+1.66
(+2.41%)
USD |
NASDAQ |
Aug 24, 16:00
70.28
0.00 (0.00%)
After-Hours: 20:00
Liquidia Total Liabilities (Quarterly) : 326.80M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 326.80M |
| March 31, 2026 | 292.95M |
| December 31, 2025 | 286.82M |
| September 30, 2025 | 253.93M |
| June 30, 2025 | 242.22M |
| March 31, 2025 | 177.72M |
| December 31, 2024 | 153.79M |
| September 30, 2024 | 142.37M |
| June 30, 2024 | 114.64M |
| March 31, 2024 | 110.86M |
| December 31, 2023 | 73.14M |
| September 30, 2023 | 63.64M |
| June 30, 2023 | 60.94M |
| March 31, 2023 | 47.28M |
| December 31, 2022 | 40.92M |
| September 30, 2022 | 37.53M |
| June 30, 2022 | 36.98M |
| March 31, 2022 | 38.14M |
| Date | Value |
|---|---|
| December 31, 2021 | 30.98M |
| September 30, 2021 | 27.34M |
| June 30, 2021 | 25.36M |
| March 31, 2021 | 25.54M |
| December 31, 2020 | 29.94M |
| September 30, 2020 | 25.83M |
| June 30, 2020 | 26.56M |
| March 31, 2020 | 31.01M |
| December 31, 2019 | 33.89M |
| September 30, 2019 | 32.69M |
| June 30, 2019 | 32.62M |
| March 31, 2019 | 36.40M |
| December 31, 2018 | 30.73M |
| September 30, 2018 | 29.37M |
| June 30, 2018 | 33.70M |
| March 31, 2018 | 33.24M |
| December 31, 2017 | 46.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 1.441B |
| Harmony Biosciences Holdings, Inc. | 373.84M |
| Johnson & Johnson | 116.09B |
| Amneal Pharmaceuticals, Inc. | 3.659B |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 521.92M |
| Shareholders Equity (Quarterly) | 195.11M |
| Debt to Equity Ratio | 0.9374 |
| Current Ratio | 2.312 |
| Net Debt Paydown Yield | -0.50% |